Revolutionary
tech for snoring and sleep apnea

Revolutionary
tech for snoring and sleep apnea

Restoring sleep for 3 billion people worldwide

$1,000

MINIMUM INVESTMENT
1.5% INVESTOR PROCESSING FEE

$1

SHARE PRICE

As Feature in
Backed By
Top Reasons to Invest
TOP REASONS TO INVEST
Rapidly Growing Market

The global sleep market is doubling to $950 Billion by 2032.1 Sleep apnea and snoring awareness is growing with 1 in 3 Americans tracking their sleep.2

Proven Demand

$31 million+ in lifetime revenues and more than 100,000 units sold. All achieved as a bootstrapped company.

Strong Patent Portfolio

Patents granted in the USA, Canada, China, Japan, Korea Europe, Australia, Hong Kong, Taiwan.

Now Launching Next Gen Product

Building on our success, with this campaign we are launching Nora Gen 2: A game-changing upgrade to an already proven product.

Ready For Growth With Top Retailers

Ready to scale with key partnerships in place with BestBuy, Target, Walmart, McKesson, Cardinal Health, Optum, Kroger and more.

Backed by Powerhouse Investors

Including seasoned Silicon Valley investors with med-tech exits and operators with more than $1B revenues in consumer brands.

Don’t miss important updates.
Receive the investor deck and timely
updates on bonus share milestones.

We care about your data in our privacy policy.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
OUR ORIGIN STORY

From an idea to 100,000 bedrooms around the world.

45% of adults lose sleep to snoring and sleep apnea.3 We invented Smart Nora to fix our own sleep issues, and took it upon ourselves to fix sleep deprivation for good!

Snoring and apnea are common, but not normal. They are linked to cardiovascular disease and mental health problems.4 Sleep deprivation in the US alone costs up to $433 billion a year.5  

The sleep health market is littered with uncomfortable and ineffective products. We believe the market is underdeveloped and ready for new thinking.

45% of adults lose sleep to snoring and sleep apnea.3 We invented Smart Nora to fix our own sleep issues, and took it upon ourselves to fix sleep deprivation for good!

Snoring and apnea are common, but not normal. They are linked to cardiovascular disease and mental health problems.4 Sleep deprivation in the US alone costs up to $433 billion a year.5  

The sleep health market is littered with uncomfortable and ineffective products. We believe the market is underdeveloped and ready for new thinking.

I'm Ready to Invest

It’s time to fix sleep
for everyone.

THE SOLUTION

Meet Nora Gen 2

Our most advanced
innovation yet.

4x

Less sleep
disruptions

30%

More rested
upon waking up

79%

Reduction in loud snoring

Smart Nora uses machine learning technology to consistently and seamlessly deliver “positional therapy”, a proven method for addressing snoring and sleep apnea. Our A.I. predicts snoring and creates gentle motions to reposition your head, restoring normal breathing—all without any electronics in your pillow.


Exclusive Perk: Investors will receive a
Nora Gen 2 ahead of retail availability.

* Study conducted by SleepScore Labs and published in Sleep Journal Oxford University Press.

*For investments of $2K and above.

4x

Less sleep
disruptions

30%

More rested
upon waking up

79%

Reduction in loud snoring

EXCEPTIONAL TRACTION

$31 million+ in lifetime revenues. 

A remarkable 30x revenue 
to funding ratio.

$31 million+ in lifetime revenues.

A remarkable 30x revenue to funding ratio.

With more than 100,000 units sold, we have scaled from concept to market leadership with strategic funding, including from Smart Nora customers, demonstrating an ability to create substantial returns on investment.

Watch: Smart Nora CEO celebrates 100,000 units milestone with Harley Finkelstein, President of Shopify.

Watch: Smart Nora CEO celebrates 100,000 units milestone with Haley Finkelstein, President of Shopify.

NEW revenue streams
Retail distribution

Retail Distribution

Smart Nora is poised for rapid expansion with major distribution agreements and FSA/HSA eligibility.

Corporate Benefits

Workforce Wellbeing

With a total addressable market of $3.7B by 2032 (7.12% CAGR) our B2B Benefits go-to-market strategy targets employer groups.6

Data and Research

Digital Health

Our digital ecosystem will integrate sleep insights with partners to deliver comprehensive lifestyle and wellness solutions.

OUR OPPORTUNITY

The global sleep market will double by 2032.

The global sleep market will double by 2032.1

We anticipate stellar growth in the
$3 billion snoring market and the
$13 billion sleep apnea market.7,8

70%

of people stop using their CPAPs within a year.9

of people stop
using their CPAPs
within a year.9

Smart Nora targets those who can not tolerate invasive solutions such as CPAP.

80%

of sleep apnea
cases are still undiagnosed.10

of sleep apnea
cases are still undiagnosed.10

There will be an unprecedented rise in awareness and demand for sleep apnea solutions. In 2024 both Apple and Samsung launched new consumer grade apnea detection features.11

The market is hungry for a truly non-invasive alternative like Smart Nora.

Since the 1980s the sleep apnea market has given rise to companies with significant valuations. These companies offer invasive solutions like CPAPs and surgical implants.

Reference 12,13,14

Reference 12, 13, 14

“Positional Therapy is effective in reducing sleep apnea events and breathing interruptions. Smart Nora packages this modality in a very comfortable product.”

Roy Raymann, PhD

Sleep NeuroScience, Ex-Apple, Ex-Philips, Keynote Speaker

“Positional Therapy is effective in reducing sleep apnea events and breathing interruptions. Smart Nora packages this modality in a very comfortable product.”

Roy Raymann, PhD

Sleep NeuroScience, Ex-Apple, Ex-Philips, Keynote Speaker

Sleep innovation is giving birth to a new wave of high-value healthcare companies.

The sleep industry has seen some spectacular exits, IPOs, and partnerships with tech giants resulting in large payouts for early investors. We believe these are the early days and even larger valuations are on the horizon.

$5 Billion Publicly listed Company
Inspire is a sleep apnea implant that requires surgery and is only available to people with severe apnea who struggle with CPAP. Despite this hurdle, Inspire has achieved a significant market cap. In comparison, Smart Nora is much easier to adopt and use.12
$5 Billion Valuation
Oura is the health and sleep-tracking ring, demonstrating the massive opportunity in sleep. Oura’s latest funding includes a strategic investment from the glucose monitoring giant Dexcom.15
$2.1 Billion Exit to Google
Fitbit was the pioneering wearable device tracking daily activity, heart rate and sleep. Fitbit’s IPO and eventual exit created significant returns for early investors.16

Invest alongside the best

Smart Nora is backed by powerhouse investors: Brian Scudamore, who's built $1B revenue in consumer brands, WeShall Investments with breadth of experience across tech startups and Santa Barbara Angels Groups with multiple med-tech exits.

You can invest with confidence, knowing field experts and experienced investors have a stake in our success.  

Watch: Hear from Brian Scudamore on why he invested in Smart Nora.

Invest early to receive bonus shares

All bonuses are additive to a maximum of 25%
Invest before Feb 7 to receive +5% bonus shares.
First 30 Days
Existing Smart Nora customers and investors will receive +5% bonus on top of any other bonus.
Invest $2,000 or more



5%

Bonus share

+ One Nora Gen 2

Invest Now
Invest $5,000 or more



10%

Bonus share

+ Two Nora Gen 2

Invest Now
Invest $10,000 or more



15%

Bonus share

+ Three Nora Gen 2

Invest Now
Invest $25,000 or more



17%

Bonus share

+ Nora Gen 2

Invest Now
Invest $25,000 or more



17%

Bonus share

+ Four Nora Gen 2

Invest Now
Invest $50,000 or more



20%

Bonus share

+ Five Nora Gen 2

Invest Now
Invest $2,000 or more



5%

Bonus share

+ One Nora Gen 2

Invest $5,000 or more



10%

Bonus share

+ Two Nora Gen 2

Invest $10,000 or more



15%

Bonus share

+ Three Nora Gen 2

Invest $25,000 or more



17%

Bonus share

+ Four Nora Gen 2

Invest $50,000 or more



20%

Bonus share

+ Five Nora Gen 2

Invest alongside the best

Smart Nora is backed by powerhouse investors: Brian Scudamore, who's built $1B revenue in consumer brands, WeShall Investments with breadth of experience across tech startups and Santa Barbara Angels Groups with multiple med-tech exits.

You can invest with confidence, knowing field experts and experienced investors have a stake in our success.  

Invest Now

Watch: Brian Scudamore on why he invested in Smart Nora on Dragon’s Den TV Show.

Watch: Hear from Brian Scudamore on why he invested in Smart Nora.

Invest early to receive bonus shares

All bonuses are additive to a maximum of 25%
Invest before Feb 7 to receive +5% bonus shares.
First 30 Days
Existing Smart Nora customers and investors will receive +5% bonus on top of any other bonus.
Invest $2,000 or more



5%

Bonus share

+ One Nora Gen 2

Invest Now
Invest $5,000 or more



10%

Bonus share

+ Two Nora Gen 2

Invest Now
Invest $10,000 or more



15%

Bonus share

+ Three Nora Gen 2

Invest Now
Invest $25,000 or more



17%

Bonus share

+ Nora Gen 2

Invest Now
Invest $25,000 or more



17%

Bonus share

+ Four Nora Gen 2

Invest Now
Invest $50,000 or more



20%

Bonus share

+ Five Nora Gen 2

Invest Now
Invest $2,000 or more



5%

Bonus share

+ One Nora Gen 2

Invest $5,000 or more



10%

Bonus share

+ Two Nora Gen 2

Invest $10,000 or more



15%

Bonus share

+ Three Nora Gen 2

Invest $25,000 or more



17%

Bonus share

+ Four Nora Gen 2

Invest $50,000 or more



20%

Bonus share

+ Five Nora Gen 2

IN THE PRESS

Smart Nora is consistently ranked as the best snoring solution.

“The device that could save your marriage... Really!”
“If you sleep with a snorer you will love Nora!”
“Compelled to scream this solution from the rooftops.”
“It’s the best solution we’ve seen.”
“This simple, small device will stop your snoring.”
“Do you sleep with a snorer? This device will save your relationship.”

Meet our dedicated
leadership team

Behrouz Hariri

Founder & CEO

20+ years in executive leadership, design Innovation, product design.

Behzad Hariri

Founder & CMO

15+ years digital marketing, D2C, consumer service, and operations.

Ali Hariri

Founder & CPO

40+ years management, R&D, engineering across industries.

Bilgehan Erdem

Chief Technology Officer

20+ years machine learning and data science leadership.

Brian Schwartz

Chief Commercial Officer

25+ years scaling businesses globally.

Woody Scal

Advisor

20 Years in High Growth Consumer-Oriented Health.

Roy Raymann, PhD

Advisor

Leader in Consumer Sleep Science.

Burc Sahinoghlu

Advisor

30 Years in Management, Cloud Computing, and R&D.

Behrouz Hariri

Founder & CEO

20+ years in executive leadership, design Innovation, product design.

Behzad Hariri

Founder & CMO

15+ years digital marketing, D2C, consumer service, and operations.

Ali Hariri

Founder & CPO

40+ years management, R&D, engineering across industries.

Bilgehan Erdem

Chief Technology Officer

20+ years machine learning and data science leadership.

Brian Schwartz

Chief Commercial Officer

25+ years scaling businesses globally.

Woody Scal

Advisor

20 Years in High Growth Consumer-Oriented Health.

Roy Raymann, PhD

Advisor

Leader in Consumer Sleep Science.

Burc Sahinoghlu

Advisor

30 Years in Management, Cloud Computing, and R&D.

It’s time to fix sleep.

Our health depends on it.

Invest Now

Frequently asked questions

Why invest in startups?

Regulation CF allows investors to invest in startups and early-growth companies. This is different from helping a company raise money on Kickstarter; with Regulation CF Offerings, you aren’t buying products or merchandise - you are buying a piece of a company and helping it grow.

How much can I invest?

Accredited investors can invest as much as they want. But if you are NOT an accredited investor, your investment limit depends on either your annual income or net worth, whichever is greater. If the number is less than $124,000, you can only invest 5% of it. If both are greater than $124,000 then your investment limit is 10%.

How do I calculate my net worth?

To calculate your net worth, just add up all of your assets and subtract all of your liabilities (excluding the value of the person’s primary residence). The resulting sum is your net worth.

What are the tax implications of an equity crowdfunding investment?

We cannot give tax advice, and we encourage you to talk with your accountant or tax advisor before making an investment.

Who can invest in a Regulation CF Offering?

Individuals over 18 years of age can invest.

What do I need to know about early-stage investing? Are these investments risky?

There will always be some risk involved when investing in a startup or small business. And the earlier you get in the more risk that is usually present. If a young company goes out of business, your ownership interest could lose all value. You may have limited voting power to direct the company due to dilution over time.  You may also have to wait about five to seven years (if ever) for an exit via acquisition, IPO, etc. Because early-stage companies are still in the process of perfecting their products, services, and business model, nothing is guaranteed. That’s why startups should only be part of a more balanced, overall investment portfolio.

When will I get my investment back?

The Common Stock (the "Shares") of Smart Nora LLC (the "Company") are not publicly-traded. As a result, the shares cannot be easily traded or sold. As an investor in a private company, you typically look to receive a return on your investment under the following  scenarios: The Company gets acquired by another company. The Company goes public (makes an initial public offering). In those instances, you receive your pro-rata share of the distributions that occur, in the case of acquisition, or you can sell your shares on an exchange. These are both considered long-term exits, taking approximately 5-10 years (and often longer) to see the possibility for an exit. It can sometimes take years to build companies. Sometimes there will not be any return, as a result of business failure.

Can I sell my shares?

Shares sold via Regulation Crowdfunding offerings have a one-year lockup period before those shares can be sold under certain conditions.

Exceptions to limitations on selling shares during the one-year lockup period:

In the event of death, divorce, or similar circumstance, shares can be transferred to:- The company that issued the securities
- An accredited investor
- A family member (child, stepchild, grandchild, parent, stepparent, grandparent, spouse or equivalent, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships)

What happens if a company does not reach their funding target?

If a company does not reach their minimum funding target, all funds will be returned to the investors after the close of the offering.

How can I learn more about a company's offering?

All available disclosure information can be found on the offering pages for our Regulation Crowdfunding offering.

What if I change my mind about investing?

You can cancel your investment at any time, for any reason, until 48 hours prior to a closing occurring. If you’ve already funded your investment and your funds are in escrow, your funds will be promptly refunded to you upon cancellation. To submit a request to cancel your investment please email: info@dealmakersecurities.com.

How do I keep up with how the company is doing?

At a minimum, the company will be filing with the SEC and posting on its website an annual report, along with certified financial statements.  Those should be available 120 days after the fiscal year end.  If the company meets a reporting exception, or eventually has to file more reported information to the SEC, the reporting described above may end. If these reports end, you may not continually have current financial information about the company.

What relationship does the company have with DealMaker Securities?

Once an offering ends, the company may continue its relationship with DealMaker Securities for additional offerings in the future.  DealMaker Securities’ affiliates may also provide ongoing services to the company. There is no guarantee any services will continue after the offering ends.

References:
  1. "Sleep Economy or Sleep Aids Market Size Worth USD 950.22 Billion in 2032," Emergen Research, Global Newswire, January 25, 2024. link
  2. "New Research Evaluates Accuracy of Sleep Trackers." Sleep Foundation, Accessed Dec. 2024. link
  3. Johns Hopkins Medicine.Why do people snore? Answers for better health. Retrieved from link
  4. Pinholster, Ginger. "Sleep Deprivation Described as a Serious Public Health Problem." American Association for the Advancement of Science. link
  5. Hafner, M., Stepanek, M., Taylor, J., Troxel, W. M., & van Stolk, C. (2017). Why sleep matters—theeconomic costs of insufficient sleep: A cross-country comparative analysis. Rand Health Quarterly,6(4), 11. link
  6. Research and Markets. United States Sleep Apnea Devices Market to 2028 - Rising Prevalence of Sleep Disorders. Yahoo Finance, 1 July 2024. link
  7. Mordor Intelligence. Anti-Snoring Treatment Market - Growth, Trends, and Forecasts (2023 - 2028). Mordor Intelligence. link
  8. Roots Analysis. Sleep Apnea Devices Market: Growth, Trends, and Forecasts. Roots Analysis. link
  9. Fortune Business Insights. (n.d.). Sleep apnea devices market size, share & industry analysis, by device type (Report No. FBI100708). link
  10. Faria A, Allen AH, Fox N, Ayas N, Laher I. The public health burden of obstructive sleep apnea. Sleep Sci. 2021 Jul-Sep;14(3):257-265.link
  11. MedTech Dive. (2024). Apple Watch's new sleep apnea and hearing features aim to improve health monitoring. MedTech Dive. link
  12. Yahoo Finance. (2025, January 5). "INSP - Inspire Medical Systems, Inc. Stock Quote." Yahoo Finance. link
  13. Yahoo Finance. (2024, December 19). "RMD - ResMed Inc. Stock Quote." Yahoo Finance. link
  14. Drakatos, Panagis, et al. "Adherence with CPAP Has Been Reported to Be Suboptimal: A Review." BMC Pulmonary Medicine, vol. 23, no. 2612, 2023. link
  15. Bala, S. (2023, November 29). Smart ring maker Oura hits $5 billion in valuation, strikes majorpartnership with Dexcom. Forbes. link
  16. Wakabayashi, D., & de la Merced, M. J. (2019, November 1). Google to buy Fitbit for $2.1billion. The New York Times. link
Equity crowdfunding investments in private placements, and start-up investments in particular, are speculative and involve a high degree of risk and those investors who cannot afford to lose their entire investment should not invest in start-ups. Companies seeking startup investment through equity crowdfunding tend to be in earlier stages of development and their business model, products and services may not yet be fully developed, operational or tested in the public marketplace. There is no guarantee that the stated valuation and other terms are accurate or in agreement with the market or industry valuations. Further, investors may receive illiquid and/or restricted stock that may be subject to holding period requirements and/or liquidity concerns.



DealMaker Securities LLC, a registered broker-dealer, and member of FINRA | SIPC, located at 4000 Eagle Point Corporate Drive, Suite 950, Birmingham, AL 35242., is the Intermediary for this offering and is not an affiliate of or connected with the Issuer. Please check our background on FINRA's BrokerCheck.

DealMaker Securities LLC does not make investment recommendations.

DealMaker Securities LLC is NOT placing or selling these securities on behalf of the Issuer.

DealMaker Securities LLC is NOT soliciting this investment or making any recommendations by collecting, reviewing, and processing an Investor's documentation for this investment.

DealMaker Securities LLC conducts Anti-Money Laundering, Identity and Bad Actor Disqualification reviews of the Issuer, and confirms they are a registered business in good standing.

DealMaker Securities LLC is NOT vetting or approving the information provided by the Issuer or the Issuer itself.

Contact information is provided for Investors to make inquiries and requests to DealMaker Securities LLC regarding Regulation CF in general, or the status of such investor’s submitted documentation, specifically. DealMaker Securities LLC may direct Investors to specific sections of the Offering Circular to locate information or answers to their inquiry but does not opine or provide guidance on issuer related matters.

This website contains forward-looking statements. These statements may include the words “believe”, “expect”, “anticipate”, “intend”, “plan”, “estimate”, “project”, “will”, “may”, “targeting” and similar expressions as well as statements other than statements of historical facts including, without limitation, those regarding the financial position, business strategy, plans, targets and objectives of the management of Smart Nora LLC (the "Company") for future operations (including development plans and objectives). Such forward-looking statements involve known and unknown risks, uncertainties and other important factors which may affect the Company's ability to implement and achieve the economic and monetary policies, budgetary plans, fiscal guidelines and other development benchmarks set out in such forward-looking statements and which may cause actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the Company's present and future policies and plans and the environment in which the Company will operate in the future. Furthermore, certain forward-looking statements are based on assumptions or future events which may not prove to be accurate, and no reliance whatsoever should be placed on any forward-looking statements in this presentation. The forward-looking statements in this website speak only as of the date of the Company's initial Form C, and the Company expressly disclaims to the fullest extent permitted by law any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained herein to reflect any change in expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.